Evidence-Based Medicine Guidelines
Treating dopamimetic psychosis in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treating Dopamimetic Psychosis in Parkinson's Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson's_disease.
Treating dopamimetic psychosis in Parkinson's disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson's_disease. Accessed September 18, 2024.
Treating dopamimetic psychosis in Parkinson's disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson's_disease
Treating Dopamimetic Psychosis in Parkinson's Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 September 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treating dopamimetic psychosis in Parkinson's disease
ID - 452339
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson's_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
